ASK REDCHAT ANYTHING ABOUT HEPION PHARMACEUTICALS INC.
Hepion Pharmaceuticals Inc. (OTCQB: HEPA)
Listen to this Section
$0.08
+0.0180
(
+29.03% )
1.3K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| HEPA-CRV431-210 (rencofilstat)DetailsNon-alcoholic steatohepatitis , Hepatitis B |
Phase 2b |
| HEPA-CRV431-207 (rencofilstat)DetailsHepatitis B, Non-alcoholic steatohepatitis |
Failed |
Market Data
|
| Open |
$0.08 |
| Previous Close |
$0.04 |
| Volume |
1.3K |
| Market Cap |
$2.33M |
| Day Range |
$0.08 - $0.08 |
| 52 Week Range |
$0.03 - $0.49 |
| Shares Outstanding |
29.12M |
| Change % |
+29.03% |
| Net Change |
▲ 0.0180 |
| Insider Ownership |
-0.01% |
| Exchange |
OTCQB |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-383,300.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-03-07 |
Sale |
-50000.00 |
Purcell Michael J. |
| 2024-02-21 |
Sale |
-85000.00 |
JACOB GARY S |
| 2024-02-21 |
Sale |
-85000.00 |
BRANCACCIO JOHN P |
| 2024-02-21 |
Sale |
-85000.00 |
Lbiati Kaouthar |
| 2024-02-21 |
Sale |
-85000.00 |
Block Timothy M. |
| 2023-11-28 |
Buy |
2500.00 |
Wijngaard Peter |
| 2023-09-20 |
Buy |
1000.00 |
Wijngaard Peter |
| 2023-09-19 |
Buy |
1600.00 |
Foster Robert T |
| 2023-09-18 |
Buy |
1600.00 |
Foster Robert T |